Remuneration
review
  Following the group’s board review in 2011, the remuneration committee (remco) was reconstituted. After five years of chairing the committee, Stuart Morris handed over responsibility to John Job, an independent non-executive director, as the new chairman of the remuneration committee. This was effective from August 2011.

Refer to page 9 of the printed report, as well as the online section of the report at www.groupfive.co.za or details of John Job’s credentials.

To ensure an effective hand over, Stuart Morris remained on the remco as an invitee for the first two committee meetings. New appointments to the committee during the financial year were Lindiwe Bakoro and Oyama Mabandla, both non-executive directors.

The remco implemented the remuneration policy as approved by shareholders by a 65.8% vote at the 2011 annual general meeting. It used its terms of reference as its guiding document on decisions made in the year.

Role of the committee

The role of the remco is to assist the board with the setting and administration of the remuneration polices of the group, as approved by the shareholders.

The group this year reviewed its approach to reporting on its remuneration and has as far as possible ensured that it complies with the principles and recommended practices of the King III report. Shareholders also provided us with their views on remuneration, which were incorporated in our principles.

The performance of the board and the executive team is appraised against a set of clear objectives and key performance areas (refer to page 102 of the printed report, as well as the online section of the report) to ensure they are remunerated fairly and responsibly.

Executive and senior management members are measured and remunerated according to the alignment, achievement and contribution to the group’s strategy, the group’s financial per for mance, business unit performance and individual performance.

Remuneration policy

The remuneration policy of Group Five is based on rewarding employees in line with company and individual performance. A pay for performance policy applies. The policy therefore aims to attract, retain and motivate skilled and performing employees to execute the current business strategy and to create sustainable growth.

The group offers an integrated remuneration and reward model which is made up of a cost to company component (CTC), a short term incentive (STI) and a long term incentive programme (LTIP). The group’s pay mix is compared to the market from which it attracts and recruits employees with the skills required by the group.

We offer an integrated approach to remuneration.

Cost to company

Base pay or guaranteed pay

Group Five benchmarks its remuneration practices against both the market from which it recruits and the most relevant markets from which employees regularly seek alternative employment. We also utilise the available reputable benchmark remuneration surveys to ensure our remuneration packages are both competitive and fair.

Accurate construction sector remuneration data remains challenging as not many construction companies participate in these remuneration surveys.

The group follows a job grading system to ensure that salaried employees are paid at a level which meets market expectations for that particular job category. The group also uses an independent remuneration consultant to ensure appropriate benchmarking of jobs and salary bands.

Our policy is to pay competent performing employees on the 62nd percentile of the market to ensure employees are competitively above the market median on their guaranteed pay. Our executives’ guaranteed pay is pegged at the median of the market while their incentives are more competitive to drive performance.

BASED ON MARKET CONDITIONS AND COMPANY PERFORMANCE, THE EXECUTIVE TEAM ELECTED TO RECEIVE A ZERO INCREASE IN BASE PAY. THE EXCEPTION TO THIS WAS TWO EXECUTIVES WHO RECEIVED MARKET-RELATED PROMOTIONAL AND TASK-RELATED BASE PAY ADJUSTMENTS. THE
OVERALL AVERAGE INCREASE FOR THE REMAINING OFFICERS OF THE COMPANY AND SALARIED EMPLOYEES WAS 5.7%.

The annual CTC increase in base pay is determined based on individual performance criteria and company financial performance being met.

Our wage-based employees are paid either in line with relevant sectoral determinations as set out by the Department of Labour or in line with union-negotiated wages.

Benefits

Group Five offers a number of employee benefits, as approved by the remuneration committee. All permanent employees are required to participate and contribute to a retirement fund. Over and above this, all salaried employees are required to be members of a medical aid either through Group Five or as a member of a spouse’s medical aid. The group also offers life assurance cover through the Group Personal Accident (GPA) fund to permanent and temporary employees. As with the base pay, the group reviews these offerings on a regular basis to ensure we remain competitive to prevailing market trends.

Variable pay

Short term incentives

The group grants management and most salaried employees an annual performance incentive. This is based on group, business unit, contract and individual performance over the past financial year of the company. Employees are measured against a set of individual, job or site-specific criteria. These standards have to
be met or exceeded for an incentive to be paid. Non-executive directors do not participate in any variable pay offering.

 

At the level of executive and prescribed officers of the company, two thresholds need to be met before an incentive pay-out is considered by the remuneration committee. These are:

Should the two thresholds be met, a maximum of 20% of profit after tax (PAT) is made available as an incentive pool. The individual incentive value is then based on a pre-determined participation percentage of company and business unit profit after tax. This is set subject to job scope and individual contribution to the group. The performance criteria and their respective weightings are as follows:

 

 

 

Executives can earn up to three times their cost to company (CTC) should they exceed their performance targets, with the expected on-target performance being 1,4 times their individual CTC. The incentive earned is divided into four tranches which are paid out respectively at six monthly intervals starting in September following the financial year end. This staggered payment contributes to retention and sustainable performance of the individual.

The remuneration committee has a discretionary clause in its mandate according to which it may consider external and internal factors that may have contributed to the thresholds not being met. They may then consider purely discretionary short term bonuses on an individual and business segment basis.

Long term incentives

The Share Appreciation Rights (SARs) scheme is currently the only long term incentive programme used by the group.

In terms of this scheme, SARs are allocated to executive and prescribed officers of the company. The intention of this scheme is to attract, retain and reward management that are able to influence the group’s performance. The performance expectation of this scheme is based on a theoretical 15% compounded annual
growth rate (CAGR) in the share price and targets to deliver an annualised average appreciation of 60% of an individual’s CTC at the time of the award.

The annual SARs allocations made are based on seniority and based on an annual multiple of an individual’s guaranteed earnings.

  Employee category   Annual
multiple of
guaranteed
earnings
(AMOGE)*
 
  CEO   1,5  
  Executive committee members   1,2  
  Managing directors of business units   0,9  
  Business unit directors (other than managing directors)   0,6  
* The SARs issued are based on the targeted AMOGE. The base number of SARs to be issued is determined by dividing the 30-day volume adjusted weighted average price achieved in the 30 days prior to the issue into the employee’s annual guaranteed cost to company package. This number is then multiplied by the AMOGE to give the seniority differentiated individualised SARs issue.

No specific performance criteria are stipulated, although it is expected that employees who are granted these SARs are employees who have and will continue to meet or exceed expectations for at least the vesting period. A vesting period of three years is applicable to this scheme. 33% of the SARs allocation can be exercised per year over the following three years with a maximum life of the scheme being seven years from the grant date.

The SARs scheme has been in existence for the last six years and was approved by shareholders in 2005.

The continued under-performance of the share price in the market downcycle rendered a negative value to all SARs issued under this scheme since inception. The scheme in its current form has therefore proven ineffective in
its ability to motivate or retain the participants to the scheme due to its reliance purely on an increasing share price performance. It therefore does not cater well for the cyclical nature of the construction sector.

To address this, a number of alternatives have been reviewed and proposed to the remuneration committee. After due consideration the committee made a recommendation to the main board for the introduction of the new long term incentive programme (LTIP) that caters for actual company performance against targets, as well as share price performance.

The board accepted this recommendation as well as approved the submission for shareholder approval. A separate circular will be issued to shareholders. The circular will detail the salient points of the proposed LTIP scheme and requires shareholder approval at the next AGM.

Employee and director contracts of employment

Permanent employees sign an employment contract that complies with the labour law requirements of the country of employment. Employees have a retirement age of 65. The CEO, executives and directors of the organisation have a retirement age of 60. The notice period of employees is one month and extends to two months for business unit directors and three months for general managers, managing directors, executives and the CEO. The group applies the standard statutory requirements
to executives should their permanent employment contract be terminated.

Non-executive directors’ fees

The remuneration committee reviews the annual increases in non-executive directors’ fees and recommends these to the board. They in turn recommend the fees to the shareholders at the annual AGM. The current fee schedule was approved by shareholders at the AGM in November 2011.

Non-executive directors are approved by shareholders. The group’s policy is that one third of directors are required to retire on an annual basis. The determination of candidates for retirement is informed by the longest-standing serving director.Therefore, depending on the size of the board, this may translate to retirement on a two or three year basis.

The chairperson of the board is remunerated on a fixed fee for the year. The rest of the non-executive board members are paid a base fee for being a main board member and then paid an attendance fee for each meeting.

The chairpersons of the sub-committees of the board are paid a fixed fee for the year and the members of these committees are. A penalty fee is applicable to a board member for failing to attend a scheduled meeting.

Details of non-executive directors’ fees are detailed below.

Remuneration committee key focus areasin the year

A key focus was to recommend a competitive rewards programme to the board to ensure that base remuneration of employees and executives balances responsible remuneration with market competitiveness and attracting the skills required.

In line with this, the committee:

Reviewed the design of the remuneration and incentive programme for the senior management of the group
Approved the pay-outs on both short and long term incentive programmes
Approved the annual employee salary increase
Reviewed and approved the executive salary reviews
Reviewed and recommended for approval to the board a proposed new long term incentive programme
Reviewed the proposal of the F2013 non-executive directors’ fees before seeking board approval
Reviewed the proposed BBBEE employee scheme and bursary foundation

The committee met quarterly as opposed to three times a year as it has done in the past. Going forward, meetings will continue to be held quarterly. The committee developed a clear strategy to continue attracting, motivating and retaining key skills in the group against pressure on profitability and to ensure that the group adheres to its pay for performance policy.

Going forward

In the coming year, the remuneration committee will review the group’s pay mix against the market trend that is leaning to offering larger guaranteed pay versus pay-at-risk or bonus pay.

 

 

 

 

 

 

 

 

 

A challenge in the coming year for remco will be to balance the need to incentivise and reward individuals who outperform while the sector still struggles with tough market conditions.

Director and senior management remuneration

Non-executive directors’ fees

  Fees, services expenses   Fees
30 June 2012
(R’000)
  Expenses
30 June 2012
(R’000)
  Total
30 June 2012
(R’000)
  Fees
30 June 2011
(R’000)
  Expenses
30 June 2011
(R’000)
  Total
30 June 2011
(R’000)
 
  Name                          
  P Buthelezi   794     794   740     740  
  LE Bakoro   401     401   394     394  
  L Chalker   517   149   666   550   223   773  
  OA Mabandla*   445     445        
  SG Morris   951     951   944     944  
  KK Mpinga   479     479   494     494  
  DDS Robertson*   450     450        
  JL Job   580     580   524     524  
      4 617   149   4 766   3 646   223   3 869  
* Appointed 1 August 2011.

Non-executive directors proposed fees F2013, subject to shareholder approval

  Position   F2013
proposed fees
(R per annum)
  Comment F2012
proposed fees
(R per annum)
 
  Main board – chairperson   782 800   Includes all board and committee attendances 739 450  
  Lead independent non-executive director   337 000   includes basic fee plus attendance fee for four meetings 318 000  
  Main board – non-executive director   195 500   includes basic fee plus attendance fee for four meetings 184 440  
  Audit committee – chairperson   195 500   Four meetings 184 440  
  Audit committee – member and attendee   98 000   Four meetings 92 430  
  Remuneration committee – chairperson   130 400   Four meetings 92 430  
  Remuneration committee – member and attendee   68 600   Four meetings 64 660  
  Risk committee – chairperson   130 400   Four meetings 122 960  
  Risk committee – member and attendee   68 600   Four meetings 64 660  
  Nominations committee – chairperson*   98 000   Two meetings 92 430  
  Nominations committee – member and attendee   51 700   Two meetings 48 760  
  SED committee – chairperson   130 400   Four meetings n/a  
  SED committee – member and attendee   68 600   Four meetings n/a  
  Extraordinary services (per hour)   2 800   Applied for ad hoc and/or non–scheduled
meetings. Capped at daily rate of R19 600
2 650  

A deduction of R13 500 per meeting will apply for non–attendance at a scheduled meeting and R28 090 will be payable for attendance at a special board meeting.

* Included in chairperson’s fee.

Executive directors

      Salaries   Performance
and equity incentives
  Total  
  (R’000)   30 June
2012
  30 June
2011*
  30 June
2012
  30 June
2011
  30 June
2012
  30 June
2011
 
  Name                          
  MR Upton   3 799   3 691   5 045   7 323   8 844   11 014  
  CMF Teixeira   2 167   2 127   2 760   3 326   4 927   5 453  
      5 966   5 818   7 805   10 649   13 771   16 467  
* 2011 has been restated to be comparable to 2012 such that both periods reflect total earnings and is more reflective of “cost to company”.

In line with the requirements of the Companies Act 2008, the group discloses the remuneration paid to prescribed officers who are defined as the group’s executive committee.

The three highest paid members of management are also reflected in the table below as per the recommended practice suggested in 2.26.2 of the King III code.

Executive committee members (exco)

      Salaries   Performance
and equity incentives
  Total  
  (R’000)   30 June
2012
  30 June
2011*
  30 June
2012
  30 June
2011
  30 June
2012
  30 June
2011
 
  Name                          
  PrescribedOfficer 1   2 793   3 048   2 822   6 052   5 615   9 100  
  PrescribedOfficer 2   2 763   2 772   2 251   3 399   5 014   6 171  
  PrescribedOfficer 3   2 531   2 533   2 870   3 545   5 401   6 078  
  PrescribedOfficer 4   2 481   2 285   1 790   3 364   4 271   5 649  
  PrescribedOfficer 5   2 080   2 011   2 380   3 081   4 460   5 092  
  PrescribedOfficer 6   1 945   2 067   2 113   2 778   4 058   4 845  
  PrescribedOfficer 7   1 890   1 838   1 932   2 766   3 822   4 604  
      16 483   16 554   16 158   24 985   32 641   41 539  

Senior managementˇ (excluding CEO, CFO and exco)

      Salaries   Performance
and equity incentives
  Total  
  (R’000)   30 June
2012
  30 June
2011*
  30 June
2012
  30 June
2011
  30 June
2012
  30 June
2011
 
  Total earnings   24 932   26 318   15 272   25 121   40 204   51 439  

The above represents earnings relating to senior managementˇ at year end date only.

Details of executive directors’ share options and share appreciations

  Name of director Options
granted
– opening
balance
Options
granted
during the
current year
Strike
price
Options
exercised
and paid
Options
lapsed
Options
granted
– closing
balance
Strike
price
Options
vested
– closing
balance
 
  MR Upton                  
  2011                  
    400 000 30,44 400 000 30,44 400 000  
    71 000 54,81 71 000 54,81 47 333  
    100 000 50,20 100 000 50,20 66 667  
    100 000 43,07 100 000 43,07 33 333  
    166 000 28,63 166 000 28,63 55 333  
    150 484 34,09 150 484 34,09  
    138 154 27,70 138 154 27,70  
    987 484 138 154   1 125 638   602 666  
  2012                  
    400 000 30,44 400 000 30,44 400 000  
    71 000 54,81 71 000 54,81 71 000  
    100 000 50,20 100 000 50,20 100 000  
    100 000 43,07 100 000 43,07 66 667  
    166 000 28,63 166 000 28,63 110 667  
    150 484 34,09 150 484 34,09 50 161  
    138 154 27,70 138 154 27,70  
    1 125 638   1 125 638   798 495  
  CMF Teixeira                  
  2011                  
    25 000 24,77 25 000 24,77 25 000  
    25 000 54,81 25 000 54,81 16 667  
    25 000 50,20 25 000 50,20 16 667  
    200 000 42,84 200 000 42,84 66 667  
    72 000 28,63 72 000 28,63 24 000  
    71 740 34,09 71 740 34,09  
    66 175 27,70 66 175 27,70  
    418 740 66 175   484 915   149 001  
  2012                  
    25 000 24,77 25 000 24,77 25 000  
    25 000 54,81 25 000 54,81 25 000  
    25 000 50,20 25 000 50,20 25 000  
    200 000 42,84 200 000 42,84 133 333  
    72 000 28,63 72 000 28,63 48 000  
    71 740 34,09 71 740 34,09 23 913  
    66 175 27,70 66 175 27,70  
    484 915   484 915   280 246  
ˇ As depicted on page 6.

Details of prescribed officers’ share options and share appreciations (including three highest paid members of management)

  Prescribed officer Options
granted
– opening
balance
Options
granted
during the
current year
Strike
price
Options
exercised
and paid
Options
lapsed
Options
granted
– closing
balance
Strike
price
Options
vested
– closing
balance
 
  Prescribed Officer 1                  
  2011                  
    18 750 12,55 18 750 12,55 18 750  
    200 000 30,44 200 000 30,44 200 000  
    42 000 54,81 42 000 54,81 28 000  
    53 000 50,20 53 000 50,20 35 333  
    100 000 28,63 100 000 28,63 33 333  
    90 818 34,09 90 818 34,09  
    83 377 27,70 83 377 27,70  
    504 568 83 377   587 945   315 416  
  2012                  
    18 750 12,55 18 750 12,55 18 750  
    200 000 30,44 200 000 30,44 200 000  
    42 000 54,81 42 000 54,81 42 000  
    53 000 50,20 53 000 50,20 53 000  
    100 000 28,63 100 000 28,63 66 667  
    90 818 34,09 90 818 34,09 30 273  
    83 377 27,70 83 377 27,70  
    587 945   587 945   410 690  
                     
  Prescribed Officer 2                  
  2011                  
    400 000 30,44 400 000 30,44  
    42 000 54,81 42 000 54,81 28 000  
    53 000 50,20 53 000 50,20 35 333  
    99 000 28,63 99 000 28,63 33 000  
    89 762 34,09 89 762 34,09  
    82 408 27,70 82 408 27,70  
    683 762 82 408   400 000 366 170   96 333  
  2012                  
    42 000 54,81 42 000 54,81 42 000  
    53 000 50,20 53 000 50,20 53 000  
    99 000 28,63 99 000 28,63 66 000  
    89 762 34,09 89 762 34,09 29 921  
    82 408 27,70 82 408 27,70  
    366 170   366 170   190 921  
                     
  Prescribed Officer 3                  
  2011                  
    125 000 30,44 125 000 30,44 125 000  
    34 000 54,81 34 000 54,81 22 667  
    150 000 50,20 150 000 50,20 100 000  
    91 000 28,63 91 000 28,63 30 333  
    81 842 34,09 81 842 34,09  
    75 469 27,70 75 469 27,70  
    481 842 75 469   557 311   278 000  
  2012                  
    125 000 30,44 125 000 30,44 125 000  
    34 000 54,81 34 000 54,81 34 000  
    150 000 50,20 150 000 50,20 150 000  
    91 000 28,63 91 000 28,63 60 667  
    81 842 34,09 81 842 34,09 27 281  
    75 469 27,70 75 469 27,70  
    557 311   557 311   396 948  
                     
  Prescribed Officer 4                  
  2011                  
    12 500 12,55 12 500 12,55  
    25 000 24,77 25 000 24,77 25 000  
    100 000 54,81 100 000 54,81 66 667  
    39 000 50,20 39 000 50,20 26 000  
    75 000 28,63 75 000 28,63 25 000  
    72 514 34,09 72 514 34,09  
    66 889 27,70 66 889 27,70  
    324 014 66 889   12 500 378 403   142 667  
  2012                  
    25 000 24,77 25 000 24,77 25 000  
    100 000 54,81 100 000 54,81 100 000  
    39 000 50,20 39 000 50,20 39 000  
    75 000 28,63 75 000 28,63 50 000  
    72 514 34,09 72 514 34,09 24 171  
    66 889 27,70 66 889 27,70  
    378 403   378 403 238 171  
                     
  Prescribed Officer 5                  
  2011                  
    150 000 51,00 150 000 51,00 100 000  
    50 000 50,20 50 000 50,20 33 333  
    68 000 28,63 68 000 28,63 22 667  
    67 938 34,09 67 938 34,09  
    62 668 27,70 62 668 27,70  
    335 938 62 668   398 606   156 000  
  2012                  
    150 000 51,00 150 000 51,00 150 000  
    50 000 50,20 50 000 50,20 50 000  
    68 000 28,63 68 000 28,63 45 333  
    67 938 34,09 67 938 34,09 22 646  
    62 668 27,70 62 668 27,70  
    398 606   398 606   267 979  
                     
  Prescribed Officer 6                  
  2011                  
    19 000 54,81     19 000 54,81 12 667  
    100 000 50,20     100 000 50,20 66 667  
    70 000   28,63     70 000 28,63 23 333  
    63 362 34,09     63 362 34,09  
    58 170 27,70     58 170 27,70  
    252 362 58 170   310 532   102 667  
  2012                  
    19 000 54,81 19 000 54,81 19 000  
    100 000 50,20 100 000 50,20 100 000  
    70 000 28,63 70 000 28,63 46 667  
    63 362 34,09 63 362 34,09 21 121  
    58 170 27,70 58 170 27,70  
    310 532   310 532   186 788  
                     
  Prescribed Officer 7                  
  2011                  
    45 000 12,55 45 000 12,55 45 000  
    300 000 30,44 150 000 150 000 30,44 150 000  
    30 000 54,81 30 000 54,81 20 000  
    37 000 50,20 37 000 50,20 24 667  
    69 000 28,63 69 000 28,63 23 000  
    61 672 34,09 61 672 34,09  
    56 619 27,70 56 619 27,70  
    542 672 56 619   150 000 449 291   262 667  
  2012                  
    45 000 12,55 45 000 12,55 45 000  
    150 000 30,44 150 000 30,44 150 000  
    30 000 54,81 30 000 54,81 30 000  
    37 000 50,20 37 000 50,20 37 000  
    69 000 28,63 69 000 28,63 46 000  
    61 672 34,09 61 672 34,09 20 557  
    56 619 27,70 56 619 27,70  
    449 291   449 291   328 557  

Details of share options and share appreciation rights issued to senior management (excluding CEO, CFO and exco)

    Options
granted
– opening
balance
Options
granted
during the
current year
Strike
price
Options
exercised
and paid
Options
lapsed
Options
granted
– closing
balance
Strike
price
Options
vested
– closing
balance
 
  2011                  
    40 000 12,28 40 000 12,28 40 000  
    75 000 20,00 75 000 20,00 75 000  
    162 500 20,25 75 000 87 500 20,25 87 500  
    350 000 24,77 350 000 24,77 350 000  
    25 000 26,39 25 000 26,39 25 000  
    75 000 31,87 75 000 31,87 75 000  
    277 000 54,81 30 000 247 000 54,81 164 667  
    377 000 50,20 42 000 335 000 50,20 223 333  
    69 389 4 147 16,03 69 389 16,03 27 159  
    100 000 33,63 100 000 33,63 33 333  
    754 505 28,63 98 000 656 505 28,63 14 168  
    714 454 34,09 714 454 34,09  
    577 766 27,70 70 755 507 011 27,70  
    3 019 848 581 913   75 000 240 755 3 281 859   1 115 160  
  2012                  
    40 000 12,28 40 000 12,28 40 000  
    97 500 24,77 97 500 24,77 97 500  
    75 000 31,87 75 000 31,87 75 000  
    177 000 54,81 177 000 54,81 177 000  
    219 000 50,20 219 000 50,20 219 000  
    116 124 16,03 23 129 92 995 16,03 43 186  
    457 000 28,63 457 000 28,63 304 667  
    412 647 34,09 412 647 34,09 137 549  
    391 943 27,70 391 943 27,70  
    1 986 214   23 129 1 963 085   1 093 902  
ˇ As depicted on page 6.